RedHill Biopharma reported $2.69M in EBIT for its fiscal quarter ending in June of 2023.





Ebit Change Date
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -7.89M 536K Sep/2025
Cronos Group USD 55.24M 59.63M Sep/2025
RedHill Biopharma USD 2.69M 47.97M Jun/2023